End-to-end operational support for Phase II–IV clinical trials, including study start-up, conduct, and close-out. We ensure efficient execution while maintaining data integrity and regulatory compliance.
Investigator-led medical oversight with continuous safety monitoring. Our team ensures protocol adherence and timely identification and reporting of adverse and serious adverse events.
Comprehensive regulatory management in alignment with ICH-GCP standards, including IRB submissions, amendments, continuing reviews, and maintenance of essential regulatory documentation.
Ethical and targeted recruitment strategies, participant screening, and retention planning to support enrollment goals and visit compliance throughout the study lifecycle.
Ethical and transparent informed consent processes supported by clear participant education. We ensure participants fully understand study requirements, risks, and responsibilities throughout their participation.
Protocol-driven clinical assessments and study visits conducted accurately and efficiently by trained research staff, ensuring consistency, data integrity, and participant safety.
Phlebotomy, specimen processing, laboratory coordination, and diagnostic testing managed in accordance with protocol requirements and sponsor guidelines.
Secure receipt, storage, dispensing, and accountability of investigational products, including temperature monitoring and reconciliation in compliance with regulatory standards.
Accurate source documentation, electronic data capture (EDC) entry, and timely query resolution to support high-quality data submission and sponsor review.
Comprehensive support for monitoring visits, audits, and inspections, with inspection-ready documentation and organized site processes maintained at all times.